Health
Ozempic Not Linked to Suicidal Thoughts, FDA Report Finds
This article is for subscribers only.
US regulators found no link between weight-loss drugs like Novo Nordisk A/S’s Ozempic and suicidal thoughts, a positive sign for the popular medications as similar reviews in Europe remain ongoing.
“Our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions,” the US Food and Drug Administration said Thursday in a statement. However, because only a small number of events have been reported, the agency said it can’t definitively rule out the risk and will continue looking at the issue.